AbbVie Inc.

ABBV· NYQ· Healthcare· Drug Manufacturers - General

$266.54

+0.83% Delayed prices.

AbbVie Inc. (ABBV) price target

From the Sep 26, 2026 report · Read the full report

Current price
$266.54
AI team's target
$278.61
Upside: +4.5%

Scenarios

We give no probability for each scenario: no reliable source estimates them and we would rather not make them up.

Base

$278.61

+4.5%

Our AI team's target

52-week range

$190.75$269.39

The team's target over time

DateCurrent ratingPricePrice target
Sep 26, 2026HOLD$264.34$278.61

Frequently asked questions

What is the ABBV price target?

Our AI team's price target for AbbVie Inc. (ABBV) is $278.61, +4.5% from the current price of $266.54.

Sources: Yahoo Finance (prices, financial statements and analysts' estimates) and the U.S. Treasury (10-year yield). Indicators and valuation are computed without AI.

AI-generated informational content. Not financial advice or a personalised investment recommendation. Investing involves risk, including loss of capital.

Every week, in your inbox

Rating changes, the highest-conviction stocks and the week's best research. Free.

By subscribing you accept the privacy policy. You can unsubscribe at any time.